Provided are methods and compositions for treating certain neurodegenerative diseases, such as RGC loss-related degenerative disease and Parkinson's Disease, using in vivo conversion of gilal cells to neurons by PTB and optionally nPTB knockdown via CRISPR/Cas delivered by viral vectors (e.g., AAV vector).
Treatment of Neuronal Diseases